Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cellular reprogramming: a new technology frontier in pharmaceutical research.

Cellular reprogramming: a new technology frontier in pharmaceutical research. Pharm Res. 2012 Jan; 29(1):35-52.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.